Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10594986 | Bioorganic & Medicinal Chemistry Letters | 2010 | 7 Pages |
Abstract
7-N-Acetamide-4-methoxy-2-aminobenzothiazole 4-fluorobenzamide (compound 1) was chosen as a drug-like and non-xanthine based starting point for the discovery of A2B receptor antagonists because of its slight selectivity against A1 and A2A receptors and modest A2B potency. SAR exploration of compound 1 described herein included modifications to the 7-N-acetamide group, substitution of the 4-methoxy group by halogens as well as replacement of the p-flouro-benzamide side chain. This work culminated in the identification of compound 37 with excellent A2B potency, modest selectivity versus A2A and A1 receptors, and good rodent PK properties.
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Adrian Wai-Hing Cheung, John Brinkman, Fariborz Firooznia, Alexander Flohr, Joseph Grimsby, Mary Lou Gubler, Kevin Guertin, Rachid Hamid, Nicholas Marcopulos, Roger D. Norcross, Lida Qi, Gwendolyn Ramsey, Jenny Tan, Yang Wen, Ramakanth Sarabu,